These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7868016)

  • 1. Risk-adjusted capitation: recent experiences in The Netherlands.
    van de Ven WP; van Vliet RC; van Barneveld EM; Lamers LM
    Health Aff (Millwood); 1994; 13(5):120-36. PubMed ID: 7868016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mandatory pooling as a supplement to risk-adjusted capitation payments in a competitive health insurance market.
    Van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    Soc Sci Med; 1998 Jul; 47(2):223-32. PubMed ID: 9720641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-adjusted capitation payments for catastrophic risks based on multi-year prior costs.
    van Barneveld EM; van Vliet RC; van de Ven WP
    Health Policy; 1997 Feb; 39(2):123-35. PubMed ID: 10165042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mandatory high-risk pooling: an approach to reducing incentives for cream skimming.
    van Barneveld EM; van Vliet RC; van de Ven WP
    Inquiry; 1996; 33(2):133-43. PubMed ID: 8675277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.
    Lamers LM
    Health Policy; 1998 Jul; 45(1):15-32. PubMed ID: 10183010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adjusted capitation. The Israeli experience.
    Shmueli A; Chinitz D
    Eur J Public Health; 2001 Jun; 11(2):182-4. PubMed ID: 11420807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
    Lamers LM; van Vliet RC; van de Ven WP
    Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-based risk adjustment: is inpatient and outpatient diagnostic information sufficient?
    Lamers LM
    Inquiry; 2001-2002 Winter; 38(4):423-31. PubMed ID: 11887959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cream-skimming, incentives for efficiency and payment system.
    Barros PP
    J Health Econ; 2003 May; 22(3):419-43. PubMed ID: 12683960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ignoring small predictable profits and losses: a new approach for measuring incentives for cream skimming.
    van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    Health Care Manag Sci; 2000 Feb; 3(2):131-40. PubMed ID: 10780281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can we prevent cream skimming in a competitive health insurance market? The great challenge for the 90's.
    Van de Ven WP; Van Vliet RC
    Dev Health Econ Public Policy; 1992; 1():23-46. PubMed ID: 10151748
    [No Abstract]   [Full Text] [Related]  

  • 12. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market-oriented health care reforms and policy learning in the Netherlands.
    Helderman JK; Schut FT; van der Grinten TE; van de Ven WP
    J Health Polit Policy Law; 2005; 30(1-2):189-209. PubMed ID: 15943393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
    van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
    Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk adjustment and risk sharing: the Israeli experience.
    Shmueli A; Chernichovsky D; Zmora I
    Health Policy; 2003 Jul; 65(1):37-48. PubMed ID: 12818744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adjusted capitation payment systems for health insurance plans in a competitive market.
    Lamers LM; van Vliet RC; van de Ven WP
    Expert Rev Pharmacoecon Outcomes Res; 2003 Oct; 3(5):541-9. PubMed ID: 19807388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed competition: issues for Australia.
    Scotton D
    Aust Health Rev; 1995; 18(1):82-104. PubMed ID: 10141965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care reform in The Netherlands: balancing corporatism, etatism, and market mechanisms.
    Schut FT
    J Health Polit Policy Law; 1995; 20(3):615-52. PubMed ID: 8530770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk adjustment in Switzerland.
    Beck K; Spycher S; Holly A; Gardiol L
    Health Policy; 2003 Jul; 65(1):63-74. PubMed ID: 12818746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a reinforced agency role of health insurers in Belgium and The Netherlands.
    Schut FT; van Doorslaer EK
    Health Policy; 1999 Jul; 48(1):47-67. PubMed ID: 10539585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.